Małgorzata Pieniążek@malgospie·21 Şubx.com/OncJournal/sta…ÇevirThe Oncologist@OncJournalIn this largest real-world cohort of metastatic #TNBC to date, the clinical benefit & manageable safety of sacituzumab govitecan seen in the ASCENT trial was confirmed in routine practice. @susanebates @gbanna74 @PasRescigno doi.org/10.1093/oncolo… ZXX00112
